The DOI matches its Crossref record; 232 of the 232 references it cites were found in a registry or an index.
Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson’s disease and Alzheimer’s disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–232 of 232
Nucleotide receptor signalling and the generation of reactive oxygen species
Guerra, A. N., Gavala, M. L., Chung, H. S., & Bertics, P. J. (2007) · Purinergic Signalling · doi:10.1007/s11302-006-9035-x · Cited by 52
Sáez, E. T., Pehar, M., Vargas, M. R., Barbeito, L., & Maccioni, R. B. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20996 · Cited by 52
P2X7 receptor-mediated reactive oxygen and nitrogen species formation: from receptor to generators
Hewinson, J., & MacKenzie, A. B. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351168 · Cited by 51
Kwon, S.-H., Ma, S., Hong, S., Kim, S. Y., Lee, S., & Jang, C. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.12.048 · Cited by 49
Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment
Chico, L., Simoncini, C., Gerfo, A. L., Rocchi, A., Petrozzi, L., Carlesi, C., Volpi, L., Tognoni, G., Siciliano, G., & Bonuccelli, U. (2013) · Free Radical Research · doi:10.3109/10715762.2013.804622 · Cited by 49
del Rio, M. A., Sánchez-Reus, M. I., Peinado, I. I., et al. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312050013 · Cited by 49
Alzheimer's Disease Pathogenesis-Core Concepts, Shifting Paradigms and Therapeutic Targets
de la Monte, S. (2011) · InTech eBooks · doi:10.5772/951 · Cited by 49
Oxidative stress impairs learning and memory in apoE knockout mice
Evola, M., Hall, A., Wall, T., Young, A. M., & Grammas, P. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.05.003 · Cited by 47
Lewy body pathology is associated with mitochondrial DNA damage in Parkinson's disease
Müller, S. K., Bender, A., Laub, C., Högen, T., Schlaudraff, F., Liss, B., Klopstock, T., & Elstner, M. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.03.016 · Cited by 47
Lee, M., Jantaratnotai, N., McGeer, E. G., McLarnon, J. G., & McGeer, P. L. (2010) · Brain Research · doi:10.1016/j.brainres.2010.10.084 · Cited by 46
Wei, L., Ding, L., Mo, M., Lei, M., Zhang, L., Chen, K., & Xu, P. (2015) · Translational Neurodegeneration · doi:10.1186/s40035-015-0033-1 · Cited by 43
Gunjima, K., Tomiyama, R., Takakura, K., Yamada, T., Hashida, K., Nakamura, Y., Konishi, T., Matsugo, S., & Hori, O. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24643 · Cited by 43
DJ‐1 forms complexes with mutant SOD1 and ameliorates its toxicity
Yamashita, S., Mori, A., Kimura, E., Mita, S., Maeda, Y., Hirano, T., & Uchino, M. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06658.x · Cited by 42
Lee, Y. K., Choi, I. S., Ban, J. O., Lee, H. J., Lee, U. S., Han, S., Jung, J., Kim, Y. H., Kim, K. H., Oh, K., et al. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.04.002 · Cited by 41
Klugman, A., Naughton, D. P., Isaac, M. G. E. K. N., Shah, I., Petróczi, A., & Tabet, N. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120124 · Cited by 36
Cho, C. H., Kim, E.-A. L., Kim, J., Choi, S. Y., Yang, S.-J., & Cho, S. (2016) · Free Radical Research · doi:10.3109/10715762.2016.1167277 · Cited by 36
Models for LRRK2-Linked Parkinsonism
Li, T., Yang, D., Sushchky, S., Liu, Z., & Smith, W. W. (2011) · Parkinson s Disease · doi:10.4061/2011/942412 · Cited by 35
Yang, H., Zhou, H., Li, B., Niu, G., & Chen, S. (2007) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-007-9082-2 · Cited by 32
Self-citationHennis, M. R., Marvin, M. A., Taylor, C. M., & Goldberg, M. S. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.09.009 · Cited by 32
Orellano, E. A., Rivera, O. J., Chevres, M., Chorna, N., & González, F. A. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0288-x · Cited by 30
Genetic Variation of Apolipoproteins in North Indians
Singh, P., Singh, M., & Mastana, S. S. (2002) · Human Biology · doi:10.1353/hub.2002.0057 · Cited by 28
Endogenous Antioxidant Activities in Relation to Concurrent Vitamins A, C, and E Intake in Dementia
Tabet, N., Mantle, D., Walker, Z., & Orrell, M. W. (2002) · International Psychogeriatrics · doi:10.1017/s1041610202008232 · Cited by 27
Melief, E. J., Cudaback, E., Jorstad, N. L., Sherfield, E., Postupna, N. O., Wilson, A. M., Darvas, M., Montine, K. S., Keene, C. D., & Montine, T. J. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23592 · Cited by 21
Gao, C., Pang, H., Luo, X., Ren, Y., Shang, H., & He, Z. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7086-9 · Cited by 21
Ringman, J. M., Cole, G. M., Teng, E., Badmaev, V., Bardens, J., Frautschy, S. A., Rosario, E. R., Fein, J., Porter, V. R., Vanek, Z. F., et al. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.2414 · Cited by 19
Can parkin be a target for future treatment of Parkinson's disease?
Kubo, S., Hatano, T., Takanashi, M., & Hattori, N. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.827173 · Cited by 15
Spatial patterns of β-amyloid (Aβ) deposits in familial and sporadic Alzheimer's disease.
Armstrong, R. A. (2011) · PubMed · Cited by 15
Roth, J. A., & Eichhorn, M. (2013) · NeuroToxicology · doi:10.1016/j.neuro.2013.04.008 · Cited by 11
Pathogenesis of sporadic Parkinson's disease: Contribution of genetic and environmental risk factors
Takahashi, R., Kawamata, J., & Takeuchi, H. (2009) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.49.885 · Cited by 10
Armstrong, R. A. (2015) · Folia Neuropathologica · doi:10.5114/fn.2015.49970 · Cited by 9
Proteasome Inhibitor Lactacystin Induces Cholinergic Degeneration
Zhou, H.-Y., Tan, Y.-Y., Wang, Z., Wang, G., Lu, G.-Q., & Chen, S.-D. (2010) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100009975 · Cited by 5
Self-citationTau Oligomers as Potential Drug Target for Alzheimer Disease (AD) Treatment
Kayed, R. (2011) · InTech eBooks · doi:10.5772/16682 · Cited by 1
Cited by
Protein misfolding in neurodegenerative diseases: Implications and strategies
Sweeney, P., Park, H., Baumann, M., Dunlop, J., Frydman, J., Kopito, R., McCampbell, A., Leblanc, G., Venkateswaran, A., Nurmi, A., et al. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0077-5 · Cited by 675
Ageing, age-related diseases and oxidative stress: What to do next?
Luo, J., Mills, K., le Cessie, S., Noordam, R., & van Heemst, D. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100982 · Cited by 581
“related proteins including α-Synuclein, Parkin, DJ-1, PINK1, LRRK2 and HTRA2 were associated with mitochondrial dysfunction as well (Jiang et al., 2016; Lin and Beal, 2006).”
BackgroundGonzález-Reyes, R. E., Nava-Mesa, M. O., Vargas-Sánchez, K., Ariza-Salamanca, D., & Mora-Muñoz, L. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00427 · Cited by 527
Neuroprotective Effect of Antioxidants in the Brain
Lee, K. H., Cha, M., & Lee, B. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197152 · Cited by 502
On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease
Giguère, N., Burke Nanni, S., & Trudeau, L.-E. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00455 · Cited by 413
Metadata
- Authors
- Jiang, T., Sun, Q., & Chen, S.
- Venue
- Progress in Neurobiology
- Publisher
- Elsevier BV
- Published
- 2016-12
- Volume
- 147
- Pages
- 1-19
- ISSN
- 0301-0082 (ISSN-L)
- OpenAlex
- W2535730691
- Cited by
- 586
- References
- 232
- FWCI
- 37.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.